- Home
- KPRX vs LUCY Comparison
KPRX vs LUCY Comparison
Compare KPRX & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- LUCY
- Stock Information
- Founded
- KPRX 1998
- LUCY 2017
- Country
- KPRX United States
- LUCY United States
- Employees
- KPRX N/A
- LUCY N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LUCY Ophthalmic Goods
- Sector
- KPRX Health Care
- LUCY Health Care
- Exchange
- KPRX Nasdaq
- LUCY Nasdaq
- Market Cap
- KPRX 8.7M
- LUCY 8.7M
- IPO Year
- KPRX N/A
- LUCY 2022
- Fundamental
- Price
- KPRX $2.71
- LUCY $1.91
- Analyst Decision
- KPRX Strong Buy
- LUCY
- Analyst Count
- KPRX 1
- LUCY 0
- Target Price
- KPRX $10.00
- LUCY N/A
- AVG Volume (30 Days)
- KPRX 80.3K
- LUCY 103.7K
- Earning Date
- KPRX 08-08-2025
- LUCY 08-14-2025
- Dividend Yield
- KPRX N/A
- LUCY N/A
- EPS Growth
- KPRX N/A
- LUCY N/A
- EPS
- KPRX N/A
- LUCY N/A
- Revenue
- KPRX N/A
- LUCY $1,978,018.00
- Revenue This Year
- KPRX N/A
- LUCY $367.48
- Revenue Next Year
- KPRX N/A
- LUCY $166.67
- P/E Ratio
- KPRX N/A
- LUCY N/A
- Revenue Growth
- KPRX N/A
- LUCY 29.30
- 52 Week Low
- KPRX $2.25
- LUCY $1.57
- 52 Week High
- KPRX $4.18
- LUCY $11.16
- Technical
- Relative Strength Index (RSI)
- KPRX 48.49
- LUCY 42.68
- Support Level
- KPRX $2.67
- LUCY $1.94
- Resistance Level
- KPRX $2.90
- LUCY $1.98
- Average True Range (ATR)
- KPRX 0.14
- LUCY 0.08
- MACD
- KPRX 0.01
- LUCY -0.00
- Stochastic Oscillator
- KPRX 39.13
- LUCY 33.33
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.